EPSTEIN BARR VIRUS (EBV) INFECTION

Clinical trials for EPSTEIN BARR VIRUS (EBV) INFECTION explained in plain language.

Never miss a new study

Get alerted when new EPSTEIN BARR VIRUS (EBV) INFECTION trials appear

Sign up with your email to follow new studies for EPSTEIN BARR VIRUS (EBV) INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Could a cancer drug stop a deadly complication in transplant patients?

Prevention Not yet recruiting

This study tests whether the drug rituximab can safely clear Epstein-Barr virus (EBV) from the blood of people who have received a solid organ transplant. High levels of EBV can lead to a serious cancer called post-transplant lymphoproliferative disorder (PTLD). The trial will en…

Matched conditions: EPSTEIN BARR VIRUS (EBV) INFECTION

Phase: PHASE1 • Sponsor: Jennifer Amengual • Aim: Prevention

Last updated Jun 02, 2026 11:58 UTC

EPSTEIN BARR VIRUS (EBV) INFECTION

Get alerted when new EPSTEIN BARR VIRUS (EBV) INFECTION trials appear

Could a cancer drug stop a deadly complication in transplant patients?